- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2019-10-09 17:10:25
- Reporting Period:
- Accepted Time:
- 2019-10-09 17:10:25
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1131324||Genomic Health Inc||GHDX||Services-Medical Laboratories (8071)||770552594|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1337798||Bradley G Cole||301 Penobscot Drive |
Redwood City CA 94063
Reported Non-Derivative Transactions
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Common Stock||Acquisiton||2019-10-07||22,560||$30.84||61,530||No||4||M||Indirect||Held by the Cole Family Trust|
|Common Stock||Disposition||2019-10-07||22,560||$69.01||38,970||No||4||S||Indirect||Held by the Cole Family Trust|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|No||4||M||Indirect||Held by the Cole Family Trust|
|No||4||S||Indirect||Held by the Cole Family Trust|
Reported Derivative Transactions
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Employee Stock Option (right to buy)||Disposition||2019-10-07||22,560||$0.00||22,560||$30.84|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- Includes an aggregate of 11,794 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 1, 2019.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $68.66 to $69.31.
- The option became exercisable as to 25% of the shares on January 28, 2015, and became exercisable as to 1/48th of the shares each full month thereafter.